Market Snapshot

BSE Sensex: 73088.33 0.83%
BSE 500: 32199.48 0.32%
BSE 200: 10088.94 0.39%
BSE 100: 23199.58 0.55%
BSE Mid-Cap: 40004.52 -0.39%
BSE Small-Cap: 45433.79 -0.04%
BANKEX: 53720.76 1.02%
BSE IT Sector: 34139.78 -0.56%
Nifty 50: 22147 0.69%
Nifty 500: 20385.2 0.30%
Nifty 200: 12325.85 0.35%
Nifty 100: 22859.8 0.53%
Nifty Midcap 100: 48696.95 -0.61%
Nifty Small 100: 16270.4 -0.10%
Nifty IT: 33368.3 -0.39%
Nifty PSU Bank: 6933.25 -0.29%

News:

ICICI Bank board to mull fund ...
Laurus Labs Andhra Pradesh fac...
Landmark Cars inks LoI with M&...
Jio Financial posts PAT of Rs ...
CRISIL upgrades rating of Tata...

Unjha Formulations Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

19 Apr 2024 | 03:59 PM

19.67

-1.58 (-7.44%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

67.98%

Return (1Y)

Beaten S&P BSE Sensex by 45.28%
More Volatile

4.23%

Standard Deviation (1Y)

Higher than S&P BSE Sensex by 3.6%
Not so consistent

6/12

Months

underperformed S&P BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Unjha Formulations to conduct board meeting
24 days ago

Unjha Formulations to conduct board meeting

27 - Mar - 2024 12:00 AM | 24 days ago

Unjha Formulations will hold a meeting of the Board of Directors of the Company on 29 March 2024. The meeting would commence at 13.00 PM.
Powered by Capital Market - Live News
Unjha Formulations reports standalone net profit of Rs 0.39 crore in the December 2023 quarter
82 days ago

Unjha Formulations reports standalone net profit of Rs 0.39 crore in the December 2023 quarter

29 - Jan - 2024 12:00 AM | 82 days ago

Net profit of Unjha Formulations reported to Rs 0.39 crore in the quarter ended December 2023 as against net loss of Rs 0.09 crore during the previous quarter ended December 2022. Sales rose 72.90% to Rs 5.55 crore in the quarter ended December 2023 as against Rs 3.21 crore during the previous quarter ended December 2022.
Particulars Quarter Ended
Dec. 2023 Dec. 2022 % Var.
Sales 5.55 3.21 73
OPM % 7.39 -2.80 -
PBDT 0.41 -0.09 LP
PBT 0.39 -0.09 LP
NP 0.39 -0.09 LP
Powered by Capital Market - Live News
Unjha Formulations to discuss results
92 days ago

Unjha Formulations to discuss results

19 - Jan - 2024 12:00 AM | 92 days ago

Unjha Formulations will hold a meeting of the Board of Directors of the Company on 29 January 2024.
Powered by Capital Market - Live News
Unjha Formulations reports standalone net loss of Rs 0.12 crore in the September 2023 quarter
162 days ago

Unjha Formulations reports standalone net loss of Rs 0.12 crore in the September 2023 quarter

10 - Nov - 2023 12:00 AM | 162 days ago

Net loss of Unjha Formulations reported to Rs 0.12 crore in the quarter ended September 2023 as against net profit of Rs 0.55 crore during the previous quarter ended September 2022. Sales rose 3.03% to Rs 4.76 crore in the quarter ended September 2023 as against Rs 4.62 crore during the previous quarter ended September 2022.
Particulars Quarter Ended
Sep. 2023 Sep. 2022 % Var.
Sales 4.76 4.62 3
OPM % -2.31 12.34 -
PBDT -0.12 0.56 PL
PBT -0.12 0.55 PL
NP -0.12 0.55 PL
Powered by Capital Market - Live News

Price vs Volume

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	5.55	3.21	73
OPM %	7.39	-2.80	-
PBDT	0.41	-0.09	LP
PBT	0.39	-0.09	LP
NP	0.39	-0.09	LP

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	4.76	4.62	3
OPM %	-2.31	12.34	-
PBDT	-0.12	0.56	PL
PBT	-0.12	0.55	PL
NP	-0.12	0.55	PL

General Notifications

My Notifications

Research Notifications

Unjha Formulations Ltd Share Price – BSE Pharmaceuticals, Small Cap

19.67 -1.58 (-7.44%)

News & Announcements

Price vs Volume

Unjha Formulations Ltd Share Price – BSE
Pharmaceuticals, Small Cap

19.67

-1.58 (-7.44%)